|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Current assets: | ||||||||||
| Cash | ||||||||||
| Cash and cash equivalents | ||||||||||
| Restricted cash | ||||||||||
| Current marketable securities | ||||||||||
| Accounts receivable, net | ||||||||||
| Contract assets, net | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Deferred transaction costs | ||||||||||
| Total current assets | ||||||||||
| Non-current assets: | ||||||||||
| Non-current marketable securities | ||||||||||
| Property and equipment, net | ||||||||||
| Operating lease right-of-use assets, net | ||||||||||
| Intangible assets, net | ||||||||||
| Goodwill | ||||||||||
| Non-current portion of contract assets | ||||||||||
| Other assets | ||||||||||
| Total non-current assets | ||||||||||
| Total assets | ||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses and other current liabilities | ||||||||||
| Accrued income taxes | ||||||||||
| Deferred revenue, current | ||||||||||
| Related party line of credit | ||||||||||
| Operating lease liabilities, current | ||||||||||
| Vendor financing obligation, current | ||||||||||
| Total current liabilities | ||||||||||
| Non-current liabilities: | ||||||||||
| Deferred revenue, non-current | ||||||||||
| Operating lease liabilities, non-current | ||||||||||
| Long-term loan facility | ||||||||||
| Vendor financing obligation, non-current | ||||||||||
| Other non-current liabilities | ||||||||||
| Total liabilities | ||||||||||
| Stockholders' equity: | ||||||||||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||
| Common stock, $0.0001 par value; 500,000,000 shares authorized; 33,682,164 and 30,948,403 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Accumulated other comprehensive loss | ||||||||||
| Total stockholders' equity | ||||||||||
| Total liabilities and stockholders' equity |
Loading...
